Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2013

Open Access 01-12-2013 | Research

Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval

Authors: Ralf Dittrich, Laura Lotz, Andreas Mueller, Inge Hoffmann, David L Wachter, Kerstin U Amann, Matthias W Beckmann, Thomas Hildebrandt

Published in: Reproductive Biology and Endocrinology | Issue 1/2013

Login to get access

Abstract

Background

New anticancer treatments have increased survival rates for cancer patients, but often at the cost of sterility. Several strategies are currently available for preserving fertility. However, the chances of achieving a pregnancy with one technique are still limited. A combination of methods is therefore recommended in order to maximize women’s chances of future fertility. In this retrospective study, ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval were combined and the quality of the ovarian tissue, the numbers and quality of oocytes, time requirements, and the safety of the strategy were examined.

Methods

Fourteen female patients suffering from malignant diseases underwent one in vitro fertilization cycle. Different stimulation protocols were used, depending on the menstrual cycle. Transvaginal oocyte retrieval was scheduled 34–36 h after human chorionic gonadotropin administration. Immediately afterwards, ovarian tissue was extracted laparoscopically.

Results

A mean of 10 oocytes were retrieved per patient, and 67% of the oocytes were successfully fertilized using intracytoplasmic sperm injection. No periprocedural complications and no complications leading to postponement of the start of chemotherapy occurred. The ovarian tissues were of good quality, with a normal age-related follicular distribution and without carcinoma cell invasion.

Conclusions

An approach using ovarian stimulation first, followed by laparoscopic collection of ovarian tissue, is a useful strategy for increasing the efficacy of fertility preservation techniques. The ovarian tissue is not affected by prior ovarian stimulation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dittrich R, Maltaris T, Hoffmann I, Oppelt PG, Beckmann MW, Mueller A: Fertility preservation in cancer patients. Minerva Ginecol. 2010, 62: 63-80.PubMed Dittrich R, Maltaris T, Hoffmann I, Oppelt PG, Beckmann MW, Mueller A: Fertility preservation in cancer patients. Minerva Ginecol. 2010, 62: 63-80.PubMed
2.
go back to reference Lawrenz B, Jauckus J, Kupka M, Strowitzki T, Wolff M: Fertility preservation in >1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet. 2011, 283: 651-656. 10.1007/s00404-010-1772-y.CrossRefPubMed Lawrenz B, Jauckus J, Kupka M, Strowitzki T, Wolff M: Fertility preservation in >1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet. 2011, 283: 651-656. 10.1007/s00404-010-1772-y.CrossRefPubMed
3.
go back to reference Rodriguez-Wallberg KA, Oktay K: Options on fertility preservation in female cancer patients. Cancer Treat Rev. 2012, 38: 354-361. 10.1016/j.ctrv.2011.10.002.CrossRefPubMed Rodriguez-Wallberg KA, Oktay K: Options on fertility preservation in female cancer patients. Cancer Treat Rev. 2012, 38: 354-361. 10.1016/j.ctrv.2011.10.002.CrossRefPubMed
4.
go back to reference Maltaris T, Beckmann MW, Dittrich R: Fertility preservation for young female cancer patients. In Vivo. 2009, 23: 123-130.PubMed Maltaris T, Beckmann MW, Dittrich R: Fertility preservation for young female cancer patients. In Vivo. 2009, 23: 123-130.PubMed
5.
go back to reference Huser M, Zakova J, Smardova L, Crha I, Janku P, Hudecek R, Ventruba P: Combination of fertility preservation strategies in young women with recently diagnosed cancer. Eur J Gynaecol Oncol. 2012, 33: 42-50.PubMed Huser M, Zakova J, Smardova L, Crha I, Janku P, Hudecek R, Ventruba P: Combination of fertility preservation strategies in young women with recently diagnosed cancer. Eur J Gynaecol Oncol. 2012, 33: 42-50.PubMed
6.
go back to reference Del Gadillo JCB, Siebzehnrübl E, Dittrich R, Wildt L, Lang N: Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study. Eur J Obstet Gynecol Reprod Biol. 2002, 102: 179-183. 10.1016/S0301-2115(01)00580-2.CrossRefPubMed Del Gadillo JCB, Siebzehnrübl E, Dittrich R, Wildt L, Lang N: Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study. Eur J Obstet Gynecol Reprod Biol. 2002, 102: 179-183. 10.1016/S0301-2115(01)00580-2.CrossRefPubMed
7.
go back to reference Bodri D, Vernaeve V, Guillén JJ, Vidal R, Figueras F, Coll O: Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial. Hum Reprod. 2006, 21: 2246-2251. 10.1093/humrep/del152.CrossRefPubMed Bodri D, Vernaeve V, Guillén JJ, Vidal R, Figueras F, Coll O: Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial. Hum Reprod. 2006, 21: 2246-2251. 10.1093/humrep/del152.CrossRefPubMed
8.
go back to reference von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T: Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2009, 92: 1360-1365. 10.1016/j.fertnstert.2008.08.011.CrossRefPubMed von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T: Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2009, 92: 1360-1365. 10.1016/j.fertnstert.2008.08.011.CrossRefPubMed
9.
go back to reference Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H: Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006, 91: 3885-3890. 10.1210/jc.2006-0962.CrossRefPubMed Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H: Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006, 91: 3885-3890. 10.1210/jc.2006-0962.CrossRefPubMed
10.
go back to reference Azim AA, Costantini-Ferrando M, Oktay K: Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008, 26: 2630-2635. 10.1200/JCO.2007.14.8700.CrossRefPubMed Azim AA, Costantini-Ferrando M, Oktay K: Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008, 26: 2630-2635. 10.1200/JCO.2007.14.8700.CrossRefPubMed
11.
go back to reference Dittrich R, Maltaris T: A simple freezing protocol for the use of an open freezing system for cryopreservation of ovarian tissue. Cryobiology. 2006, 52: 166-10.1016/j.cryobiol.2005.11.005.CrossRefPubMed Dittrich R, Maltaris T: A simple freezing protocol for the use of an open freezing system for cryopreservation of ovarian tissue. Cryobiology. 2006, 52: 166-10.1016/j.cryobiol.2005.11.005.CrossRefPubMed
12.
go back to reference Ata B, Chian RC, Tan SL: Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients. Best Pract Res Clin Obstet Gynaecol. 2010, 24: 101-112. 10.1016/j.bpobgyn.2009.11.007.CrossRefPubMed Ata B, Chian RC, Tan SL: Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients. Best Pract Res Clin Obstet Gynaecol. 2010, 24: 101-112. 10.1016/j.bpobgyn.2009.11.007.CrossRefPubMed
13.
go back to reference Sonmezer M, Oktay K: Fertility preservation in female patients. Hum Reprod Update. 2004, 10: 251-266. 10.1093/humupd/dmh021.CrossRefPubMed Sonmezer M, Oktay K: Fertility preservation in female patients. Hum Reprod Update. 2004, 10: 251-266. 10.1093/humupd/dmh021.CrossRefPubMed
14.
go back to reference Noyes N, Knopman JM, Melzer K, Fino ME, Friedman B, Westphal LM: Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online. 2011, 23: 323-333. 10.1016/j.rbmo.2010.11.011.CrossRefPubMed Noyes N, Knopman JM, Melzer K, Fino ME, Friedman B, Westphal LM: Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online. 2011, 23: 323-333. 10.1016/j.rbmo.2010.11.011.CrossRefPubMed
15.
go back to reference Yoon TK, Lee DR, Cha SK, Chung HM, Lee WS, Cha KY: Survival rate of human oocytes and pregnancy outcome after vitrification using slush nitrogen in assisted reproductive technologies. Fertil Steril. 2007, 88: 952-956. 10.1016/j.fertnstert.2006.12.071.CrossRefPubMed Yoon TK, Lee DR, Cha SK, Chung HM, Lee WS, Cha KY: Survival rate of human oocytes and pregnancy outcome after vitrification using slush nitrogen in assisted reproductive technologies. Fertil Steril. 2007, 88: 952-956. 10.1016/j.fertnstert.2006.12.071.CrossRefPubMed
16.
go back to reference von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, Salle B, Sonmezer M, Andersen CY: Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy—a technique in its infancy but already successful in fertility preservation. Eur J Cancer. 2009, 45: 1547-1553. 10.1016/j.ejca.2009.01.029.CrossRefPubMed von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, Salle B, Sonmezer M, Andersen CY: Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy—a technique in its infancy but already successful in fertility preservation. Eur J Cancer. 2009, 45: 1547-1553. 10.1016/j.ejca.2009.01.029.CrossRefPubMed
17.
go back to reference Rosendahl M, Greve T, Andersen CY: The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet. 2013, 30: 11-24. 10.1007/s10815-012-9912-x.PubMedCentralCrossRefPubMed Rosendahl M, Greve T, Andersen CY: The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet. 2013, 30: 11-24. 10.1007/s10815-012-9912-x.PubMedCentralCrossRefPubMed
18.
go back to reference Donnez J, Jadoul P, Pirard C, Hutchings G, Demylle D, Squifflet J, Smitz J, Dolmans MM: Live birth after transplantation of frozen–thawed ovarian tissue after bilateral oophorectomy for benign disease. Fertil Steril. 2012, 98: 720-725. 10.1016/j.fertnstert.2012.05.017.CrossRefPubMed Donnez J, Jadoul P, Pirard C, Hutchings G, Demylle D, Squifflet J, Smitz J, Dolmans MM: Live birth after transplantation of frozen–thawed ovarian tissue after bilateral oophorectomy for benign disease. Fertil Steril. 2012, 98: 720-725. 10.1016/j.fertnstert.2012.05.017.CrossRefPubMed
19.
go back to reference Silber S, Kagawa N, Kuwayama M, Gosden R: Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril. 2010, 94: 2191-2196. 10.1016/j.fertnstert.2009.12.073.CrossRefPubMed Silber S, Kagawa N, Kuwayama M, Gosden R: Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril. 2010, 94: 2191-2196. 10.1016/j.fertnstert.2009.12.073.CrossRefPubMed
20.
go back to reference Revel A, Laufer N, Ben Meir A, Lebovich M, Mitrani E: Micro-organ ovarian transplantation enables pregnancy: a case report. Hum Reprod. 2011, 26: 1097-1103. 10.1093/humrep/der063.CrossRefPubMed Revel A, Laufer N, Ben Meir A, Lebovich M, Mitrani E: Micro-organ ovarian transplantation enables pregnancy: a case report. Hum Reprod. 2011, 26: 1097-1103. 10.1093/humrep/der063.CrossRefPubMed
21.
go back to reference Dittrich R, Lotz L, Keck G, Hoffmann I, Mueller A, Beckmann MW, van der Ven H, Montag M: Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012, 97: 387-390. 10.1016/j.fertnstert.2011.11.047.CrossRefPubMed Dittrich R, Lotz L, Keck G, Hoffmann I, Mueller A, Beckmann MW, van der Ven H, Montag M: Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012, 97: 387-390. 10.1016/j.fertnstert.2011.11.047.CrossRefPubMed
22.
go back to reference Huober-Zeeb C, Lawrenz B, Popovici RM, Strowitzki T, Germeyer A, Stute P, von Wolff M: Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined. Fertil Steril. 2011, 95: 342-344. 10.1016/j.fertnstert.2010.07.1074.CrossRefPubMed Huober-Zeeb C, Lawrenz B, Popovici RM, Strowitzki T, Germeyer A, Stute P, von Wolff M: Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined. Fertil Steril. 2011, 95: 342-344. 10.1016/j.fertnstert.2010.07.1074.CrossRefPubMed
23.
go back to reference Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, Kuperwasser C: Systemic stromal effects of estrogen promote the growth of estrogen receptor–negative cancers. Cancer Res. 2007, 67: 2062-2071. 10.1158/0008-5472.CAN-06-3895.CrossRefPubMed Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, Kuperwasser C: Systemic stromal effects of estrogen promote the growth of estrogen receptor–negative cancers. Cancer Res. 2007, 67: 2062-2071. 10.1158/0008-5472.CAN-06-3895.CrossRefPubMed
24.
go back to reference Checa Vizcaíno MA, Corchado AR, Sastre I, Cuadri ME, Comadran MG, Brassesco M, Carreras R: The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women. Reprod Biomed Online. 2012, 24: 606-610. 10.1016/j.rbmo.2012.02.020.CrossRefPubMed Checa Vizcaíno MA, Corchado AR, Sastre I, Cuadri ME, Comadran MG, Brassesco M, Carreras R: The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women. Reprod Biomed Online. 2012, 24: 606-610. 10.1016/j.rbmo.2012.02.020.CrossRefPubMed
25.
go back to reference Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z: Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod. 2003, 18: 90-95. 10.1093/humrep/deg045.CrossRefPubMed Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z: Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod. 2003, 18: 90-95. 10.1093/humrep/deg045.CrossRefPubMed
26.
go back to reference Oktay K, Türkçüoğlu I, Rodriguez-Wallberg KA: GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online. 2010, 20: 783-788. 10.1016/j.rbmo.2010.03.004.PubMedCentralCrossRefPubMed Oktay K, Türkçüoğlu I, Rodriguez-Wallberg KA: GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online. 2010, 20: 783-788. 10.1016/j.rbmo.2010.03.004.PubMedCentralCrossRefPubMed
27.
go back to reference Humaidan P: Agonist trigger: what is the best approach? Agonist trigger and low dose hCG. Fertil Steril. 2012, 97: 529-530. 10.1016/j.fertnstert.2011.11.016.CrossRefPubMed Humaidan P: Agonist trigger: what is the best approach? Agonist trigger and low dose hCG. Fertil Steril. 2012, 97: 529-530. 10.1016/j.fertnstert.2011.11.016.CrossRefPubMed
28.
go back to reference Dolmans MM, Demylle D, Martinez-Madrid B, Donnez J: Efficacy of in vitro fertilization after chemotherapy. Fertil Steril. 2005, 83: 897-901. 10.1016/j.fertnstert.2004.08.035.CrossRefPubMed Dolmans MM, Demylle D, Martinez-Madrid B, Donnez J: Efficacy of in vitro fertilization after chemotherapy. Fertil Steril. 2005, 83: 897-901. 10.1016/j.fertnstert.2004.08.035.CrossRefPubMed
29.
go back to reference Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG: Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod. 2001, 16: 632-637. 10.1093/humrep/16.4.632.CrossRefPubMed Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG: Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod. 2001, 16: 632-637. 10.1093/humrep/16.4.632.CrossRefPubMed
30.
go back to reference Huang JYJ, Tulandi T, Holzer H, Tan SL, Chian RC: Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril. 2008, 89: 567-572. 10.1016/j.fertnstert.2007.03.090.CrossRefPubMed Huang JYJ, Tulandi T, Holzer H, Tan SL, Chian RC: Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril. 2008, 89: 567-572. 10.1016/j.fertnstert.2007.03.090.CrossRefPubMed
31.
go back to reference Fasano G, Moffa F, Dechène J, Englert Y, Demeestere I: Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation. Reprod Biol Endocrinol. 2011, 9: 150-10.1186/1477-7827-9-150.PubMedCentralCrossRefPubMed Fasano G, Moffa F, Dechène J, Englert Y, Demeestere I: Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation. Reprod Biol Endocrinol. 2011, 9: 150-10.1186/1477-7827-9-150.PubMedCentralCrossRefPubMed
32.
go back to reference Suikkari AM: In-vitro maturation: its role in fertility treatment. Curr Opin Obstet Gynecol. 2008, 20: 242-248. 10.1097/GCO.0b013e3282f88e33.CrossRefPubMed Suikkari AM: In-vitro maturation: its role in fertility treatment. Curr Opin Obstet Gynecol. 2008, 20: 242-248. 10.1097/GCO.0b013e3282f88e33.CrossRefPubMed
33.
go back to reference Badawy A, Elnashar A, El-Ashry M, Shahat M: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril. 2009, 91: 694-697. 10.1016/j.fertnstert.2007.12.044.CrossRefPubMed Badawy A, Elnashar A, El-Ashry M, Shahat M: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril. 2009, 91: 694-697. 10.1016/j.fertnstert.2007.12.044.CrossRefPubMed
34.
go back to reference von Wolff M, Montag M, Dittrich R, Denschlag D, Nawroth F, Lawrenz B: Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet. 2011, 284: 427-435. 10.1007/s00404-011-1874-1.PubMedCentralCrossRefPubMed von Wolff M, Montag M, Dittrich R, Denschlag D, Nawroth F, Lawrenz B: Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet. 2011, 284: 427-435. 10.1007/s00404-011-1874-1.PubMedCentralCrossRefPubMed
Metadata
Title
Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval
Authors
Ralf Dittrich
Laura Lotz
Andreas Mueller
Inge Hoffmann
David L Wachter
Kerstin U Amann
Matthias W Beckmann
Thomas Hildebrandt
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2013
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-11-19

Other articles of this Issue 1/2013

Reproductive Biology and Endocrinology 1/2013 Go to the issue